These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25128267)

  • 21. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
    Blonde L; Ginsberg BH; Horn S; Hirsch IB; James B; Mulcahy K; Nettles A; Smout R; Wright H
    Diabetes Care; 2002 Jan; 25(1):245-6. PubMed ID: 11772926
    [No Abstract]   [Full Text] [Related]  

  • 22. The Hormone Foundation's: Patient guide to continuous glucose monitoring.
    Tamborlane WV; Vigersky RA
    J Clin Endocrinol Metab; 2011 Oct; 96(10):29A-30A. PubMed ID: 21976752
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonadjunctive Use of Continuous Glucose Monitoring: The End of Fingersticks?
    Beck RW; Brown SA; Lum JW; Kovatchev BP
    Diabetes Technol Ther; 2020 Feb; 22(2):67-68. PubMed ID: 31657622
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous Glucose Monitoring in 2015.
    Battelino T; Bode BW
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 1():S10-21. PubMed ID: 26836422
    [No Abstract]   [Full Text] [Related]  

  • 25. Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice.
    Nardacci EA; Bode BW; Hirsch IB
    Diabetes Educ; 2010; 36 Suppl 1():4S-19S; quiz 20S-21S. PubMed ID: 20407139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palm glucose readings compared with fingertip readings under steady and dynamic glycemic conditions, using the OneTouch Ultra Blood Glucose Monitoring System.
    Kempe KC; Budd D; Stern M; Ellison JM; Saari LA; Adiletto CA; Olin B; Price DA; Horwitz DL
    Diabetes Technol Ther; 2005 Dec; 7(6):916-26. PubMed ID: 16386098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10 commonly asked questions about diabetes.
    Gusek A
    Am J Nurs; 1994 Feb; 94(2):19-20. PubMed ID: 8304391
    [No Abstract]   [Full Text] [Related]  

  • 28. The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients.
    Nyomba BL; Berard L; Murphy LJ
    Diabetes Care; 2002 Jul; 25(7):1244-5. PubMed ID: 12087028
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuous and Intermittent Glucose Monitoring in 2019.
    Battelino T; Dovc K; Bode BW
    Diabetes Technol Ther; 2020 Feb; 22(S1):S3-S16. PubMed ID: 32069158
    [No Abstract]   [Full Text] [Related]  

  • 30. Brief report: Comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin.
    Burt MG; Roberts GW; Aguilar-Loza NR; Stranks SN
    Diabetes Technol Ther; 2013 Mar; 15(3):241-5. PubMed ID: 23360391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous glucose monitoring: the next step toward closing the loop.
    Shamoon H
    Diabetes Technol Ther; 2000; 2(1):57-9. PubMed ID: 11467322
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of an Integrated Tool for Interpretation of Blood Glucose Data Improves Correctness of Glycemic Risk Assessment in Individuals With Type 1 and Type 2 Diabetes.
    Parkin CG; Schwenke S; Ossege AK; Gruchmann T
    J Diabetes Sci Technol; 2017 Jan; 11(1):74-82. PubMed ID: 27621144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency of self-monitoring in relation to metabolic control in patients with type I and type II diabetes treated at the diabetic clinic of the Institute of Agricultural Medicine in Lublin].
    Latalski M; Jaworska J; Dziemidok P
    Wiad Lek; 2002; 55 Suppl 1():305-12. PubMed ID: 15002260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of continuous glucose monitoring in type 2 diabetic patients].
    Corcillo A; Girardin S; Andrey M; Le Dizès O; Jornayvaz FR
    Rev Med Suisse; 2017 May; 13(565):1140-1144. PubMed ID: 28639756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucose sensors in tissue, glucose monitoring and controlled insulin administration].
    Pfeiffer EF
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():12-5. PubMed ID: 8839105
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin management of type I and type II diabetes in pregnancy.
    Hare JW
    Clin Obstet Gynecol; 1991 Sep; 34(3):494-504. PubMed ID: 1934701
    [No Abstract]   [Full Text] [Related]  

  • 40. The FDA reevaluates alternative site testing for blood glucose.
    Ginsberg BH
    Diabetes Technol Ther; 2002; 4(3):347-9. PubMed ID: 12165174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.